Introduction: Valvular deposits of calcium quantified by transthoracic echocardiography are associated with the occurrence of systemic atherosclerotic disease, but its prognostic value and influence of associated cardiovascular risk factors have not been defined yet.
Introduction
Studies have shown that calcium deposits in the cardiovascular system are associated with atherosclerotic disease. [1] [2] [3] [4] Similar to computed tomography (CT), bidimensional transthoracic echocardiography (TTE) is capable of detecting cardiac calcium deposits, and is a portable, noninvasive, nonradioactive, and low-cost method. 5 Coronary angiotomography is known to predict individual risk of coronary events, evaluating the calcium score of the coronary arteries and the semiquantitative scores of valvular calcium. 5 A study by Gaibazzi et al. 6 has established a cardiac calcification index by TTE and predicted the presence of important coronary calcification, with results comparable to those of coronary angiotomography. 6 In patients with coronary artery disease (CAD), mitral annular calcification and aortic valve sclerosis on TTE are independent risk factors for cardiovascular events. 7 Some studies have shown that calcium deposition in the aortic leaflets and fibrous skeleton at the base of the heart is related to aging. In the elderly, up to 55% of the bidimensional TTEs demonstrate calcifications. 8, 9 Other studies have shown that the absence of cardiac calcification is a stronger predictor of absence of coronary disease than the absence of traditional risk factors, with the exception of diabetes mellitus (DM). 10 Mitral annular calcification is associated with calcification of other cardiac structures, such as the aortic root, papillary muscles, chordae tendineae, and aortic valves, suggesting that it may be a result of a degenerative process that increases with age, or secondary to increased valvular stress. 11 As a result of the increased turbulence and mechanical stress, the aortic valve serves as a focus of deposition of lipids involved in the process of atherosclerosis. Histopathological studies of aortic valves with valve sclerosis show accumulation of atherogenic lipoproteins, infiltration of inflammatory cells, extracellular matrix, and microscopic calcifications. 12 Finally, aortic valve sclerosis may be related to systemic atherosclerosis and cardiovascular events, but its usefulness in predicting CAD is questionable. 13 The aim of this study was to correlate the cardiac calcification index on TTE with cardiovascular risk factors and the presence of CAD.
Methods
This observational, cross-sectional study evaluated consecutive outpatients users of the public health system who underwent TTE with quantification of the cardiac calcification index from May 2015 to February 2016.
Patients
Among the outpatient population referred by the attending physician for TTE due to any clinical indication, we selected patients of both genders, older than 18 years of age, and of any race. The exclusion criteria were patients with chronic kidney disease undergoing dialysis, since these patients show changes in calcium metabolism and ectopic calcification associated with the renal dysfunction, patients with prosthetic heart valves, and patients with valvular stenosis, due to calcification of the valves being due primarily to mechanical stress. The following clinical data were evaluated: age, gender, body mass index (BMI), hypertension, DM, CAD, smoking (current or previous), dyslipidemia, and use of medications (statins, angiotensin-converting enzyme inhibitors [ACEIs], angiotensin receptor blockers [ARBs], aspirin, and beta-blockers). The diagnoses of hypertension, DM, dyslipidemia, and smoking were retrieved from medical records and/or reported by the patients. The presence of CAD was confirmed by data from medical records and included the occurrence of non-fatal myocardial infarction and surgical or percutaneous myocardial revascularization.
All patients signed two copies of a free and informed consent form and retained one of the copies. The study was approved by the local Research Ethics Committee (CAAE 58034716.9.0000.0093).
Echocardiographic equipment
We used the following echocardiographic equipment with enabled harmonic imaging software: Philips iE33, Philips Envisor, and Vivid (GE). The examinations were performed by two experienced echocardiographers, and the composite valvular cardiac calcium index was calculated according to the Gaibazzi score 6 (Table 1 ) by a cardiologist blinded to the patients' clinical data. This score defines aortic valvular sclerosis as focal areas of increased reflectivity and thickening of the aortic valve leaflet in the absence of aortic stenosis (transvalvular speed < 2.5 m/sec). Each aortic valve leaflet is graded on a scale of 0 (normal) to 3 (severe) according to leaflet thickening and calcium deposits; the highest score given to a particular leaflet is designated as the overall degree of aortic valve sclerosis. Mitral annular calcification is defined as a hyperreflective and bright structure located at the junction between the atrioventricular groove and the posterior mitral valve leaflet, measured from the leading anterior to the posterior edge of the valve leaflet and graded on a scale of 0 (normal) to 3 (severe). Papillary muscle calcification is determined in the presence of a hyperreflective area in the head of one or both papillary muscles. Aortic root calcification is defined by the presence of a focal or diffuse hyperreflective area and aortic annular thickening in the parasternal short-axis. The final score is the sum of all identified calcium deposits and ranges from 0 (no visible calcification) to 8 (extensive cardiac and aortic annular calcification deposits). 
Statistical analysis
We described quantitative variables as mean, median, minimum and maximum values, and standard deviation. To summarize the qualitative variables, we used frequencies and percentages. We compared two classifications of a single variable in relation to a quantitative variable with Student's t test for independent samples. To evaluate the association between two qualitative variables, we used the chi-square test and Fisher's exact test. To evaluate the combined association of variables of interest with the presence of CAD, we fitted a logistic regression model using Wald's test to evaluate the statistical significance of each variable included in the model. P values lower than 0.05 indicated statistical significance.
Results

Population characteristics
In all, we evaluated 203 patients with a mean age of 61.2 ± 14.3 years, 117 (57.6%) of whom were female. The most prevalent risk factors were hypertension, dyslipidemia, and smoking ( Table 2 ). The medications mostly used by the patients were ACEI/ARB (65.5%) and beta-blockers (45.3%).
Calcification indices
With respect to the presence of valvular calcifications, 41% of the study population presented visible calcifications on TTE, while this index increased to 58.8% in patients older than 65 years (n = 90). In the overall sample, 16% of the calcifications observed affected both the valves, 15% affected only the aortic valve, and 9% affected only the mitral valve ( Table 3) .
As for the distribution of the indices, 59% of the patients presented a valvular cardiac calcium index of 0 (no calcification), 29.5% presented an index of 1 or 2, and 11.3% had an index of 3, 4 or 5. None of the patients had calcification indices between 6 and 8.
With respect to the calcium index and patients' age, there was a statistically significant difference (p < 0.001) between patients with a calcium index of 0 (mean age 56.9 years) and those with calcium indices of 1 or 2 (mean age 65.6 years) and 3, 4 or 5 (mean age of 72.1 years).
With respect to the calcium index versus presence of hypertension, we observed that 50.7% of the hypertensive patients (versus 81.8% of the non-hypertensive ones) presented a calcium index of 0; 35.8% (versus 12.7% of non-hypertensive ones) had indices between 1 and 2; and 13.5% (versus 5.5% of non-hypertensive ones) had indices of 3, 4 or 5. From these data, we conclude that hypertension is associated with the presence of calcification (p < 0.001).
Risk factors and combined mitral and aortic valvular cardiac calcification
The present study showed an independent association between age above 65 years and the presence of valvular cardiac calcification (p < 0.001), as shown in Figure 1 . It also revealed an independent association between the presence of hypertension and the occurrence of valvular cardiac calcification (p < 0.001), as shown in Figure 2 
Risk factors and mitral valve calcification
The risk factors associated with mitral annular or papillary muscle calcification were age over 65 years 
40.
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Discussion
The present study identified the occurrence of mitral valve annular calcification as a risk factor independently and significantly associated with CAD. This fact has been already demonstrated in necropsy 1 and population studies, which have shown the occurrence of calcium deposits in the cardiovascular system of individuals with atherosclerotic disease. [2] [3] [4] TTE is a practical tool to assess cardiac calcium and its efficacy is comparable to that of angiotomography, as demonstrated in the Heinz Nixdorf Recall study, published in JAMA in 2010. 5 There is no standardization in regards to the quantification of cardiac calcium on TTE, and the present study used the Gaibazzi 6 score for this purpose.
Numerous studies have correlated cardiac calcium to established CAD. A 2015 study published in the American Journal of Cardiology 7 including 595 outpatients with stable CAD undergoing TTE has shown that the risk of death was higher in patients with a calcium score ≥ 2, even when adjusted for age, previous revascularization, DM, diastolic blood pressure, and glomerular filtration rate. However, the presence of cardiac calcification did not emerge as an independent risk factor in our study patients with previous CAD.
A 2006 study published in Circulation 12 attempted to determine whether atherosclerotic calcification of multiple vascular areas would be significantly associated with mitral and aortic annular calcification, independently of traditional risk factors. To determine that, the study evaluated the extension of the atherosclerotic calcification by CT of five vascular beds and mitral and aortic annular calcification in 1,242 patients. It observed that 24% of the patients had aortic annular calcification and 8% had mitral annular calcification, and that age and hypertension were the only cardiovascular risk factors independently associated with the prevalence of these calcifications. We found similar results in the present study: 41% of the study population showed some degree of valvular cardiac calcification on TTE, whereas 15% had calcification only in the aortic valve and 9% only in the mitral valve. Similarly, only age and hypertension emerged as risk factors independently associated with valvular calcification.
Other studies have shown that calcium deposition in the aortic leaflets and cardiac fibrous skeleton (mitral and aortic annuli) is related to the aging process. In elderly individuals, up to 55% of the bidimensional echocardiographic examinations demonstrate valvular calcifications. 8, 9 At this age, aortic valve sclerosis was identified in 54% of the patients, mitral annular calcification in 42%, and aortic annular calcification in 44%. A combination of all three calcifications was present in 17% of the patients. Patients with calcifications were older than those without calcifications. Similarly, the present study found a higher prevalence of calcification in patients older than 65 years (58.8% had cardiac calcifications), and a 5% increase in odds of mitral valve calcification and 10% in aortic valve calcification at each additional year of age.
A study has shown that patients with mitral annular calcification have cardiovascular, renal, metabolic, and functional profiles worse than those with aortic ring calcification or aortic valve sclerosis. The same study also demonstrated that the more intense the calcification, the greater is the relationship with cardiovascular disease. When the risk was adjusted for the presence of DM, hypertension, previous CAD, ankle-brachial index (ABI) ≤ 0.9, serum creatinine ≥ 1.5 mg/dL, carotid stenosis ≥ 25%, left ventricular ejection fraction (LVEF), and myocardial mass (g), only mitral annular calcification was associated with cardiovascular disease.
14 Similarly, the present study revealed in the multivariate analysis that the presence of CAD and age above 65 years are independent risk factors for the presence of mitral annular and/or papillary muscle calcification.
Although several studies have shown a connection between aortic valve sclerosis and risk factors for atherosclerosis and cardiovascular morbidity, the data are still controversial. A 2015 study by Bhatt et al. 13 attempted to determine the association between the presence or absence of aortic valve sclerosis and cardiovascular risk factors, CAD extent, and severity of coronary lesions. After allocating 482 patients evaluated with coronary cineangiography into two groups, with and without valvular sclerosis, age was the only independent predictor of aortic valve sclerosis. Aortic valve sclerosis was also not independently associated with the number of obstructed vessels or degree of obstruction, showing that it is probably a benign marker of senile degenerative cardiac changes, regardless of the severity and complexity of the CAD. Finally, aortic valve sclerosis may be related to systemic atherosclerosis and cardiovascular events, but its usefulness in predicting CAD is questionable. In the present study, multivariate analysis revealed that only age was an independent risk factor for the presence of aortic valve calcification. In contrast, some studies have considered the absence of aortic root calcification and mitral annular calcification as a stronger predictor of absence of coronary disease than the absence of traditional risk factors, with the exception of DM. 15 The use of ACEIs, aspirin, beta-blockers, and statins was frequent among the patients in this study due to the prevalence of hypertension and dyslipidemia in these individuals. There is no treatment based on evidence to reduce or prevent mitral annular calcification, and it unknown whether commonly used medications such as aspirin, beta-blockers, and statins may prevent its pathogenesis. Several studies suggest that warfarin is associated with increased valvular calcification.
11
Although Bhatt et al. 13 found no association between hypercholesterolemia and mitral annular calcification, further studies are needed to determine whether the use of statins would affect prognosis in these patients. Although many patients in the present study used drugs such as ACEIs (65.5% of the patients), aspirin (45.8%), and statin (17.7%), the study was not delineated to correlate the use of drugs and the presence of cardiac calcification.
Some factors have limited this study. First, the study population consisted mainly of elderly and hypertensive patients, since these patients were referred to TTE from an outpatient cardiology clinic. Second, the clinical diagnoses of the risk factors were established by self-report by the patients or through information obtained by review of their medical records. Another limiting factor of the study was the relative subjectivity in the quantification of cardiac calcification. Finally, the medications used by the patients were not included in the multivariate analysis.
Conclusion
The present study concluded that age above 65 years and hypertension were independent risk factors for the presence of valvular cardiac calcification, with mitral valvular calcification alone significantly and independently associated with the presence of CAD.
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